Cafepharma Today

April 26 2024 - Why the obesity drug market is about to get a lot more crowded
Why the obesity drug market is about to get a lot more crowded
Pfizer hemophilia gene therapy arrives in US to uncertain future
AbbVie lifts profit forecast after Skyrizi sales beat expectations
Walgreens rolls out gene, cell therapy services
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Q&A: Legend Biotech CEO on whether Carvykti can meet expectations
Medical Marketing and Media
Monday, April 15, 2024 - 11:16am
tags:
Legend Biotech, Carvykti, mutliple myeloma, JNJ
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
Biopharma Reporter
Monday, April 15, 2024 - 11:11am
tags:
Pfizer, Velsipity, UK, ulcerative colitis
4 Investigational Weight Loss Drugs That Could Change the Market
BioSpace
Monday, April 15, 2024 - 11:09am
tags:
weight loss, Novo Nordisk, CagriSema, Eli Lilly, orforglipro, Viking Therapeutics, VK-2735, Inversago Pharma, INV-202
Roche’s Columvi offers survival benefit in Phase III DLBCL trial
Clinical Trials Arena
Monday, April 15, 2024 - 11:07am
tags:
Roche, clinical trials, Columvi, DLBCL
AbbVie Touts Long-Term Efficacy of Qulipta as Preventive Migraine Treatment
BioSpace
Monday, April 15, 2024 - 11:06am
tags:
AbbVie, clinical trials, migraines, Qulipta
Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond
Fierce Biotech
Monday, April 15, 2024 - 11:04am
tags:
Regeneron, funding, venture capital, biotech
A two-decade bet on Seagen pays off
Stat
Monday, April 15, 2024 - 11:03am
tags:
Pfizer, Seagen, M&A
Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits
Fierce Biotech
Monday, April 15, 2024 - 11:00am
tags:
Neumora Therapeutics, schizophrenia, FDA, clinical trials, NMRA-266
Activist hedge fund seeks big shake-up at Novavax
Pharmaphorum
Monday, April 15, 2024 - 10:59am
tags:
Novavax, Shah Capital, activist investors
Rinvoq reclaims top Rx, OTC pharma brand crown
Medical Marketing and Media
Sunday, April 14, 2024 - 1:29pm
tags:
AbbVie, Rinvoq, OTC advertising
Merck Paid $208 Million to Stop Its Drugs From Working
Motley Fool
Sunday, April 14, 2024 - 1:27pm
tags:
Merck, M&A, Abceutics, antibody-drug conjugate
Roche, Adaptimmune part ways on cell therapy research
BioPharma Dive
Sunday, April 14, 2024 - 1:26pm
tags:
Roche, Genentech, cell therapy, cancer, Adaptimmune
Lady Gaga’s latest Nurtec ad is out and fans have something to say about it
Medical Marketing and Media
Sunday, April 14, 2024 - 1:25pm
tags:
Pfizer, migraines, Nurtec, celebrity endorsements
Candel wins FDA orphan drug designation for pancreatic cancer drug
Clinical Trials Arena
Sunday, April 14, 2024 - 1:23pm
tags:
FDA, Candel Therapeutics, CAN-2409, pancreatic cancer, orphan drugs
Nigeria becomes first country to roll out new meningitis vaccine, WHO says
Reuters
Sunday, April 14, 2024 - 1:22pm
tags:
Nigeria, WHO, Men5CV, vaccines, meningitis
With 9% pay hike, Merck CEO Robert Davis entered $20M compensation club in 2023
Fierce Pharma
Sunday, April 14, 2024 - 1:20pm
tags:
Merck, Pharma CEOs, Robert Davis, executive compensation
Vaccines, next-gen approaches target the toughest cancers: AACR
BioSpace
Friday, April 12, 2024 - 11:36am
tags:
cancer, oncology, AACR, vaccines
Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing
Fierce Biotech
Friday, April 12, 2024 - 11:23am
tags:
Novartis, MorphoSys, pelabresib, myelofibrosis, M&A, BET inhibitor
AstraZeneca Expands Fasenra’s Label to Younger Children with Severe Asthma
BioSpace
Friday, April 12, 2024 - 11:15am
tags:
AstraZeneca, Fasenra, severe asthma, FDA, eosinophilic asthma, pediatric
Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy
BioSpace
Friday, April 12, 2024 - 11:13am
tags:
Eli Lilly, tirzepatide, legal, compounding pharmacies

Pages

Latest CP Wire Articles

PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility
Eastman introduces new excipient to formulate poorly soluble API

Latest Pharmagather Articles

How GoodRx is Evolving Its Reimbursement Approaches to Help Pharmacies and Consumers
Drug Channels
The Top 15 Specialty Pharmacies of 2023: Market Shares and Revenues at the Biggest PBMs, Health Plans, and Independents
Drug Channels
How Patient Engagement Can Reduce Brand Launch Risks
Drug Channels
The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead
Drug Channels
SAVE THE DATE: Drug Channels Leadership Forum, March 17-19, 2025
Drug Channels
Tales of the Unsurprised: U.S. Brand-Name Drug Prices Fell for an Unprecedented Sixth Consecutive Year—And Will Fall Further in 2024 (rerun)
Drug Channels
Vertical Integration Lessons: The Economics and Strategies of Hospital-Owned Specialty Pharmacies (rerun)
Drug Channels
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup (rerun)
Drug Channels
What CVS Pharmacy’s New Cost-Plus Reimbursement Approach Means for PBMs, Pharmacies, Plan Sponsors, and Prescription Prices (rerun)
Drug Channels

Latest Jobs

Account Executive - Hospice
Kansas City, MO, 64190
Agape Care Group
Area Manager-Specialty Mid-South
Fields, OR, 97710
CSL Behring
Account Executive - Hospice
Garden City, MO, 64747
Agape Care Group
Account Executive - Hospice
Holden, MO, 64040
Agape Care Group
Account Executive - Hospice
Harrisonville, MO, 64701
Agape Care Group
Account Executive - Hospice
Freeman, MO, 64746
Agape Care Group
Account Executive - Hospice
Higginsville, MO, 64037
Agape Care Group
Area Manager, Immunology West
Coffeyville, KS, 67337
CSL Behring
Area Manager-Immunology Southeast
Fields, OR, 97710
CSL Behring
Area Manager-Specialty, Delaware Valley
Fields, OR, 97710
CSL Behring
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information